Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 5
2010 13
2011 9
2012 14
2013 7
2014 20
2015 19
2016 17
2017 14
2018 13
2019 16
2020 20
2021 26
2022 46
2023 36
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Results by year

Filters applied: . Clear all
Page 1
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.
Papi A, Ison MG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Campora L, Dezutter N, de Schrevel N, Fissette L, David MP, Van der Wielen M, Kostanyan L, Hulstrøm V; AReSVi-006 Study Group. Papi A, et al. N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604. N Engl J Med. 2023. PMID: 36791160 Clinical Trial.
Waste Management and the Perspective of a Green Hospital-A Systematic Narrative Review.
Lattanzio S, Stefanizzi P, D'ambrosio M, Cuscianna E, Riformato G, Migliore G, Tafuri S, Bianchi FP. Lattanzio S, et al. Among authors: tafuri s. Int J Environ Res Public Health. 2022 Nov 28;19(23):15812. doi: 10.3390/ijerph192315812. Int J Environ Res Public Health. 2022. PMID: 36497884 Free PMC article. Review.
Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study.
Venerito V, Stefanizzi P, Cantarini L, Lavista M, Galeone MG, Di Lorenzo A, Iannone F, Tafuri S, Lopalco G. Venerito V, et al. Among authors: tafuri s. Int J Mol Sci. 2023 Apr 9;24(8):6967. doi: 10.3390/ijms24086967. Int J Mol Sci. 2023. PMID: 37108130 Free PMC article.
Efficacy and safety of respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons.
Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D; AReSVi-006 study group. Ison MG, et al. Clin Infect Dis. 2024 Jan 22:ciae010. doi: 10.1093/cid/ciae010. Online ahead of print. Clin Infect Dis. 2024. PMID: 38253338
Editorial: Occupational Medicine: Disease Risk Factors and Health Promotion.
Jurisic V, Ledda C, Mucci N, Tafuri S, Vimercati L. Jurisic V, et al. Among authors: tafuri s. Front Public Health. 2022 Jan 25;9:819545. doi: 10.3389/fpubh.2021.819545. eCollection 2021. Front Public Health. 2022. PMID: 35145948 Free PMC article. No abstract available.
Vaccinations among athletes: evidence and recommendations.
Tafuri S, Sinesi D, Gallone MS. Tafuri S, et al. Expert Rev Vaccines. 2017 Sep;16(9):867-869. doi: 10.1080/14760584.2017.1358092. Epub 2017 Jul 25. Expert Rev Vaccines. 2017. PMID: 28724336 No abstract available.
243 results